Brain, Vol. 116, No. 4, 811-821, 1993
© 1993 Guarantors of Brain
research-article |
Brain MRI changes in phenylketonuria: Associations with dietary status
1Institute of Neurology London, UK 2Institute of Child Health London, UK 3Rayne Institute, University College London, UK
Correspondence to:
Correspondence to: Dr Alan Thompson, The Institute of Neurology, Queen Square, London WCIN 3BG, UK.
Following the introduction 30 years ago of neonatal screening and early dietary treatment for phenylketonuria there has been a dramatic decrease in the severity of neurological dysfunction associated with this disorder. However, there is evidence that subtle neurological impairment remains common in early treated subjects and in the last 3 years there have been a number of reports of overt neurological impairment with white matter abnormalities on MRI. The frequency of white matter changes in phenylketonuria, and the relation of these changes to dietary management, have remained unclear. The present study examines MRI findings in 34 subjects aged 8–33 years. Twenty-five subjects had been detected by routine neonatal screening and nine had been missed in the screening programme. At the time of the investigation 16 of the early treated and two of the late treated subjects were still receiving a diet low in phenylalanime. All but two of the 34 subjects showed abnormalities on MRI. In the early diagnosed group it could be shown that the severity of MRI changes (graded 1–5) was significantly and independently associated with phenylalanine concentrations at the time of investigation and the time since dietary treatment had been withdrawn. These data are consistent with studies in animals showing that hyperphenylalaninaemia increases myelin turnover in a dose dependent manner. It is suggested that the effects of phenylalanine on myelin pose a lifelong hazard to the nervous system.
Received August 28, 1992. Revised February 15, 1993. Accepted March 22, 1993.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Perez-Duenas, J. Pujol, C. Soriano-Mas, H. Ortiz, R. Artuch, M. A. Vilaseca, and J. Campistol Global and regional volume changes in the brains of patients with phenylketonuria Neurology, April 11, 2006; 66(7): 1074 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. H. Pfaendner, G. Reuner, J. Pietz, G. Jost, D. Rating, V. A. Magnotta, A. Mohr, B. Kress, K. Sartor, and S. Hahnel MR Imaging-Based Volumetry in Patients with Early-Treated Phenylketonuria AJNR Am. J. Neuroradiol., August 1, 2005; 26(7): 1681 - 1685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kono, Y. Okano, K. Nakayama, Y. Hase, S. Minamikawa, N. Ozawa, H. Yokote, and Y. Inoue Diffusion-weighted MR Imaging in Patients with Phenylketonuria: Relationship between Serum Phenylalanine Levels and ADC Values in Cerebral White Matter Radiology, August 1, 2005; 236(2): 630 - 636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Tada, J. Takanashi, A. J. Barkovich, H. Oba, M. Maeda, H. Tsukahara, M. Suzuki, T. Yamamoto, T. Shimono, T. Ichiyama, et al. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion Neurology, November 23, 2004; 63(10): 1854 - 1858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-i. Takanashi, A. J. Barkovich, K.-i. Yamaguchi, and Y. Kohno Influenza-Associated Encephalitis/Encephalopathy with a Reversible Lesion in the Splenium of the Corpus Callosum: A Case Report and Literature Review AJNR Am. J. Neuroradiol., May 1, 2004; 25(5): 798 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. E. Moller, J. Weglage, U. Bick, D. Wiedermann, R. Feldmann, and K. Ullrich Brain Imaging and Proton Magnetic Resonance Spectroscopy in Patients With Phenylketonuria Pediatrics, December 1, 2003; 112(6): 1580 - 1583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Courtney-Martin, R. Bross, M. Raffi, J. T. R. Clarke, R. O. Ball, and P. B. Pencharz Phenylalanine requirement in children with classical PKU determined by indicator amino acid oxidation Am J Physiol Endocrinol Metab, December 1, 2002; 283(6): E1249 - E1256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Phillips, P. McGraw, M. J. Lowe, V. P. Mathews, and B. E. Hainline Diffusion-Weighted Imaging of White Matter Abnormalities in Patients with Phenylketonuria AJNR Am. J. Neuroradiol., September 1, 2001; 22(8): 1583 - 1586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Leuzzi, D. Fois, C. Carducci, I. Antonozzi, and G. Trasimeni Neuropsychological and Neuroradiological (MRI) Variations During Phenylalanine Load: Protective Effect of Valine, Leucine, and Isoleucine Supplementation J Child Neurol, August 1, 1997; 12(5): 338 - 340. [PDF]
|
|